Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Erica Kollmann

1355 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks

Why Precision BioSciences Stock Is Up Today

By Erica Kollmann
January 9, 12:39 PM
Precision BioSciences, Inc. (NASDAQ: DTIL) shares are trading higher Tuesday after the company announced it has signed a licensing agreement wit

DTIL

Read More
1 minute read
  • Movers
  • News

What’s Going On With TG Therapeutics Stock?

By Erica Kollmann
January 9, 12:36 PM
TG Therapeutics, Inc. (NASDAQ: TGTX) shares are trading lower Tuesday, though the stock remains up 18% over the past five days. Here's a look at what's going on.

TGTX

Read More
1 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks

What’s Going On With Elevation Oncology Stock?

By Erica Kollmann
January 8, 5:16 PM
Elevation Oncology, Inc. (NASDAQ: ELEV) shares raced higher Monday. The company announced program updates and upcoming 2024 milestones on Friday.

ELEV

Read More
1 minute read
  • Movers
  • News
  • Small Cap

What’s Going On With Cancer Drug-Developer Nkarta Stock?

By Erica Kollmann
January 8, 4:51 PM
Nkarta, Inc. (NASDAQ: NKTX) shares are blasting higher Monday, and the stock has gained more than 270% over the past month. Here's a look at what's going on.

NKTX

Read More
1 minute read
  • Movers
  • News
  • Penny Stocks
  • Small Cap

Why Dada Nexus Stock Is Dropping

By Erica Kollmann
January 8, 2:06 PM
Dada Nexus Limited (NASDAQ: DADA) shares are trading lower Monday after the company said that in the course of its routine internal audit, certain suspicious practices were identified that may cast doubt on some revenues from the company's online advertising and marketing services in 2023.

DADA

Read More
1 minute read
  • Movers
  • News
  • Small Cap

What’s Going On With Beyond Inc Stock?

By Erica Kollmann
January 8, 2:01 PM
Beyond, Inc. (NYSE: BYON) shares are moving Monday, and the stock is up more than 9% over the past month. Here's a look at what to know. What To Know:

BYON

Read More
1 minute read
  • Movers
  • News
  • Small Cap

What’s Going On With BioCryst Pharmaceuticals Stock?

By Erica Kollmann
January 8, 12:41 PM
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) shares are trading higher Monday.

BCRX

Read More
1 minute read
  • Movers
  • News
  • Small Cap

What’s Going On With Ardelyx Stock?

By Erica Kollmann
January 8, 12:03 PM
Ardelyx, Inc. (NASDAQ: ARDX) shares are trading higher Monday after the company provided a strategic business update.

ARDX

Read More
1 minute read
  • Movers
  • News
  • Small Cap

Why Aclarion Stock Is Trading Higher Today

By Erica Kollmann
January 8, 11:08 AM
Aclarion, Inc. (NASDAQ: ACON) shares are trading higher Monday after the company announced it has executed a strategic partnership agreement solidifying the previously signed Letter of Intent (LOI) with Alphatec Spine, Inc.,

ACON

Read More
2 minute read
  • Global
  • Legal
  • Media
  • News
  • Tech
  • Top Stories

Apple May Soon Face Antitrust Lawsuit From Department of Jusice: Report

By Erica Kollmann
January 5, 5:48 PM
Apple Inc (NASDAQ: AAPL) could soon become the next major tech company to face a federal antitrust lawsuit. 

AAPL

Posts pagination

Previous 1 … 65 66 67 … 136 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service